Trial Profile
STUDY TO EVALUATE SAFETY OF BENZALKONIUM CHLORIDE FREE LATANOPROST OPHTHALMIC SOLUTION 0.005% IN SUBJECTS WITH GLAUCOMA.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Latanoprost (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- Sponsors Sun Pharma Advanced Research Company
- 23 Apr 2015 New trial record